ZA200801351B - Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors - Google Patents

Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors

Info

Publication number
ZA200801351B
ZA200801351B ZA200801351A ZA200801351A ZA200801351B ZA 200801351 B ZA200801351 B ZA 200801351B ZA 200801351 A ZA200801351 A ZA 200801351A ZA 200801351 A ZA200801351 A ZA 200801351A ZA 200801351 B ZA200801351 B ZA 200801351B
Authority
ZA
South Africa
Prior art keywords
sulphonypyrrole
histone deacetylases
hydrochloride salts
deacetylases inhibitors
inhibitors
Prior art date
Application number
ZA200801351A
Other languages
English (en)
Inventor
Maier Thomas
Beckers Thomas
Hummel Rolf-Peter
Feth Martin
Mueller Matthias
Baer Thomas
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of ZA200801351B publication Critical patent/ZA200801351B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200801351A 2005-09-21 2008-02-08 Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors ZA200801351B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05108716 2005-09-21

Publications (1)

Publication Number Publication Date
ZA200801351B true ZA200801351B (en) 2009-09-30

Family

ID=35810290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801351A ZA200801351B (en) 2005-09-21 2008-02-08 Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors

Country Status (16)

Country Link
US (1) US8188138B2 (ru)
EP (1) EP1928826B1 (ru)
JP (1) JP5305909B2 (ru)
KR (1) KR101314158B1 (ru)
CN (1) CN101287706A (ru)
AR (1) AR055647A1 (ru)
AU (1) AU2006298881A1 (ru)
BR (1) BRPI0616040A2 (ru)
CA (1) CA2622670A1 (ru)
EA (1) EA018698B1 (ru)
IL (1) IL189781A0 (ru)
NO (1) NO20081796L (ru)
NZ (1) NZ566073A (ru)
TW (1) TWI382971B (ru)
WO (1) WO2007039403A1 (ru)
ZA (1) ZA200801351B (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
CA2526636C (en) 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
KR101130556B1 (ko) * 2004-03-11 2012-03-30 4에스체 악티엔게젤샤프트 Ｈｄａｃ 억제제로서의 설포닐피롤
MXPA06012394A (es) 2004-04-30 2007-01-31 Bayer Pharmaceuticals Corp Derivados de pirazolilurea sustituidos utiles en el tratamiento de cancer.
CA2622673C (en) * 2005-09-21 2017-06-27 Thomas Maier Sulphonylpyrroles and use thereof as inhibitors of hdac s
WO2008127659A2 (en) * 2007-04-13 2008-10-23 University Of Texas Southwestern Medical Center Combination therapy for cancer
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
EP2100878A1 (en) 2008-03-12 2009-09-16 4Sc Ag Novel method for the production of sulphonylpyrroles as HDAC inhibitors
EP2330894B8 (en) 2008-09-03 2017-04-19 BioMarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
DK2680694T3 (en) 2011-02-28 2019-03-25 Biomarin Pharm Inc HISTONDEACETYLASE INHIBITORS
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
KR101781922B1 (ko) 2012-04-10 2017-09-26 안지 파마슈티컬 코퍼레이션 리미티드 히스톤 탈아세틸효소(hdacs) 억제제
ES2680224T3 (es) 2013-03-15 2018-09-05 Biomarin Pharmaceutical Inc. Inhibidores de HDAC
RU2657783C2 (ru) 2013-09-30 2018-06-15 Тайхо Фармасьютикал Ко., Лтд. Комбинированная терапия с использованием азабициклосоединения для ракового заболевания
EP3490973B1 (en) 2016-07-26 2021-06-23 Fresenius Kabi Oncology Ltd Polymorphic forms of belinostat and processes for preparation thereof
CA3063111C (en) 2017-05-16 2022-10-11 Annji Pharmaceutical Co., Ltd. Histone deacetylases (hdacs) inhibitors
WO2021121266A1 (zh) * 2019-12-16 2021-06-24 广州辑因医疗科技有限公司 扩增造血干细胞的小分子化合物及其组合
KR20230104109A (ko) 2020-06-08 2023-07-07 안지 파마슈티컬 코퍼레이션 리미티드 선택적 hdac6 억제제로서 유용한 퀴나졸린 유도체

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
JP3342485B2 (ja) 1991-12-10 2002-11-11 塩野義製薬株式会社 芳香族スルホンアミド系ヒドロキサム酸誘導体
CA2223154A1 (en) * 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
GB9807354D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US7141593B1 (en) * 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations
EP1233958B1 (en) 1999-11-23 2011-06-29 MethylGene Inc. Inhibitors of histone deacetylase
WO2001038323A1 (en) 1999-11-23 2001-05-31 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
NZ529118A (en) * 2001-05-22 2005-10-28 Pfizer Prod Inc Crystal forms of azithromycin
KR20040022238A (ko) 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
BR0212510A (pt) 2001-09-14 2004-08-24 Methylgene Inc Inibidor de histona desacetilase, composto e composição
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
US6821502B2 (en) * 2002-06-12 2004-11-23 Chevron U.S.A. Inc. Method of making aluminum-containing zeolite with IFR structure
CA2497060C (en) 2002-08-29 2014-05-20 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
EP1663204B1 (en) 2003-08-29 2014-05-07 Exelixis, Inc. C-kit modulators and methods of use
EP1709007A1 (en) 2004-01-22 2006-10-11 Altana Pharma AG N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
KR101130556B1 (ko) * 2004-03-11 2012-03-30 4에스체 악티엔게젤샤프트 Ｈｄａｃ 억제제로서의 설포닐피롤
US7345043B2 (en) * 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
US7351833B2 (en) * 2004-07-23 2008-04-01 Abbott Laboratories (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
US8436176B2 (en) * 2004-12-30 2013-05-07 Medicis Pharmaceutical Corporation Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
EP1861365B1 (en) 2005-03-15 2009-07-01 4Sc Ag N-sulphonylpyrroles and their use as histone deacetylase inhibitors
ATE510821T1 (de) 2005-04-07 2011-06-15 4Sc Ag Sulfonylpyrrole als histondeacetylaseinhibitoren
UA91546C2 (ru) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(b-D-ГЛЮКОПИРАНОЗ-1- ИЛ)-2-[4-((S)- ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ЕЕ ПРИМЕНЕНИЕ ПРИ ПРИГОТАВЛЕНИИ ЛЕКАРСТВЕННЫХ СРЕДСТВ
MY152185A (en) * 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
PT1924585E (pt) * 2005-08-29 2012-01-19 Sanofi Aventis Us Llc Nova forma cristalina de um derivado de piridazino[4,5-b]indole
JP2008522983A (ja) * 2005-09-13 2008-07-03 シコール インコーポレイティド ロクロニウムブロミドの合成方法
CA2622673C (en) * 2005-09-21 2017-06-27 Thomas Maier Sulphonylpyrroles and use thereof as inhibitors of hdac s
CN101528212A (zh) * 2006-09-28 2009-09-09 默克公司 Hdac抑制剂和可螯合的金属化合物的药物组合物以及金属-hdac抑制剂螯合物
US7837978B2 (en) * 2006-10-13 2010-11-23 Chevron U.S.A. Inc. Process for preparing aluminum-containing molecular sieve SSZ-26
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
WO2008143500A1 (en) * 2007-05-22 2008-11-27 Ultimorphix Technologies B.V. Tenofovir disoproxil hemi-fumaric acid co-crystal
TW200944520A (en) * 2008-01-29 2009-11-01 Glaxo Group Ltd Spiro compounds as NPY Y5 receptor antagonists

Also Published As

Publication number Publication date
KR20080046730A (ko) 2008-05-27
US20090297473A1 (en) 2009-12-03
EA200800791A1 (ru) 2009-04-28
JP5305909B2 (ja) 2013-10-02
TW200745027A (en) 2007-12-16
JP2009508825A (ja) 2009-03-05
AR055647A1 (es) 2007-08-29
AU2006298881A1 (en) 2007-04-12
KR101314158B1 (ko) 2013-10-04
WO2007039403A1 (en) 2007-04-12
CA2622670A1 (en) 2007-04-12
US8188138B2 (en) 2012-05-29
BRPI0616040A2 (pt) 2011-06-07
CN101287706A (zh) 2008-10-15
EP1928826B1 (en) 2013-04-24
EA018698B1 (ru) 2013-10-30
EP1928826A1 (en) 2008-06-11
TWI382971B (zh) 2013-01-21
IL189781A0 (en) 2008-08-07
NO20081796L (no) 2008-04-17
NZ566073A (en) 2011-08-26

Similar Documents

Publication Publication Date Title
ZA200801351B (en) Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors
IL188692A0 (en) Histone deacetylase inhibitors
HK1110579A1 (en) New histone deacetylases inhibitors
EP1945617A4 (en) HISTONDEACETYLASEINHIBITORS WITH ARYLPYRAZOLYL MOTIVES
ZA201002841B (en) Histone deacetylase inhibitors
EP2170076A4 (en) 4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONDEACETYLASE INHIBITORS
IL193458A0 (en) Histone deacetylase inhibitors
EP1771167A4 (en) INHIBITORS OF HISTONE DEACETYLASE
HRP20130683T1 (en) Benzamide compounds useful as histone deacetylase inhibitors
EP2049124A4 (en) PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
EP1991247A4 (en) BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS
EP2049505A4 (en) ISOFORM SELECTIVE HDAC HEMMER
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
HK1144070A1 (zh) 肽脫甲酰基酶抑制劑
ZA200806983B (en) Amide derivative or salt thereof
IL189112A0 (en) NOVEL HETEROCYCLIC NF-kB INHIBITORS
HK1099300A1 (en) Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
EP1784386A4 (en) HISTONE DEACETYLASE INHIBITORS
EP1784194A4 (en) HISTONE DEACETYLASE INHIBITORS
EP2205070A4 (en) N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE
EP2231596A4 (en) INHIBITORS OF HISTONATE ACETYLASE
EP2205563A4 (en) NEW HISTONDEACETYLASE INHIBITORS
EP1817020A4 (en) INHIBITORS OF HISTONATE ACETYLASE